184 related articles for article (PubMed ID: 29217291)
21. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.
Yang Z; Lin F; Qin B; Liang Y; Zhong R
J Rheumatol; 2015 Feb; 42(2):282-91. PubMed ID: 25448790
[TBL] [Abstract][Full Text] [Related]
22. Increased long-term risk of heart failure and other adverse cardiac outcomes in dermatomyositis and polymyositis: Insights from a nationwide cohort.
Yafasova A; Diederichsen LP; Schou M; Sun G; Torp-Pedersen C; Gislason GH; Fosbøl EL; Køber L; Butt JH
J Intern Med; 2021 Sep; 290(3):704-714. PubMed ID: 34080737
[TBL] [Abstract][Full Text] [Related]
23. Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis.
Liu M; Zhao Z; Lu K; Luo Q; Zhao T; Wang H
J Clin Hypertens (Greenwich); 2023 Nov; 25(11):1019-1026. PubMed ID: 37814496
[TBL] [Abstract][Full Text] [Related]
24. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis].
Zuo C; Wei XD; Ye YL; Liang Y; Yin G; Yang M; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):801-4, 809. PubMed ID: 24325116
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
Zhang L; Wu G; Gao D; Liu G; Pan L; Ni L; Li Z; Wang Q
PLoS One; 2016; 11(5):e0155381. PubMed ID: 27171228
[TBL] [Abstract][Full Text] [Related]
26. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Chen YJ; Wu CY; Shen JL
Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy outcome in idiopathic inflammatory myopathy.
Váncsa A; Ponyi A; Constantin T; Zeher M; Dankó K
Rheumatol Int; 2007 Mar; 27(5):435-9. PubMed ID: 17033833
[TBL] [Abstract][Full Text] [Related]
28. Prognosis and mortality of polymyositis and dermatomyositis patients.
Airio A; Kautiainen H; Hakala M
Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398
[TBL] [Abstract][Full Text] [Related]
29. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular diastolic dysfunction -- early cardiac impairment in patients with polymyositis/dermatomyositis: a tissue Doppler imaging study.
Lu Z; Wei Q; Ning Z; Qian-Zi Z; Xiao-Ming S; Guo-Chun W
J Rheumatol; 2013 Sep; 40(9):1572-7. PubMed ID: 23908445
[TBL] [Abstract][Full Text] [Related]
31. Mortality trends in polymyositis and dermatomyositis: A general population-based study.
Li L; D'Silva KM; Lu N; Huang K; Esdaile JM; Choi HK; Aviña-Zubieta JA
Semin Arthritis Rheum; 2020 Oct; 50(5):834-839. PubMed ID: 32896696
[TBL] [Abstract][Full Text] [Related]
32. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
33. The Prevalence of Dementia among Dermatomyositis and Polymyositis Patients: A Retrospective Cohort Study.
Patt YS; Ben-Shabat N; Fisher L; Amital H; Watad A; Sharif K
Isr Med Assoc J; 2023 Jul; 25(7):479-484. PubMed ID: 37461173
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis-A Retrospective Cohort Analysis.
Sharif K; Ben-Shabat N; Mahagna M; Shani U; Watad A; Cohen AD; Amital H
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556929
[No Abstract] [Full Text] [Related]
35. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
[TBL] [Abstract][Full Text] [Related]
36. Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.
Lee CW; Muo CH; Liang JA; Sung FC; Hsu CY; Kao CH
Endocrine; 2016 Apr; 52(1):86-92. PubMed ID: 26429781
[TBL] [Abstract][Full Text] [Related]
37. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.
Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M
Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the association of dermatomyositis and polymyositis with cancer.
Wang J; Guo G; Chen G; Wu B; Lu L; Bao L
Br J Dermatol; 2013 Oct; 169(4):838-47. PubMed ID: 23909921
[TBL] [Abstract][Full Text] [Related]
39. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
40. Reasons for Hospitalization and In-Hospital Mortality in Adults With Dermatomyositis and Polymyositis.
Pavon MR; Sanchez JE; Pescatore J; Edigin E; Richardson C; Manadan A
J Clin Rheumatol; 2022 Mar; 28(2):e433-e439. PubMed ID: 34262001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
